AMP Deaminase Inhibitors. 5. Design, Synthesis, and SAR of a Highly Potent Inhibitor Series

2001 ◽  
Vol 44 (4) ◽  
pp. 613-618 ◽  
Author(s):  
Srinivas Rao Kasibhatla ◽  
Brett C. Bookser ◽  
Wei Xiao ◽  
Mark D. Erion
ChemInform ◽  
2010 ◽  
Vol 32 (25) ◽  
pp. no-no
Author(s):  
Srinivas Rao Kasibhatla ◽  
Brett C. Bookser ◽  
Wei Xiao ◽  
Mark D. Erion

1996 ◽  
Vol 39 (2) ◽  
pp. 619-622 ◽  
Author(s):  
Paul F. Jackson ◽  
Derek C. Cole ◽  
Barbara S. Slusher ◽  
Susan L. Stetz ◽  
Laurie E. Ross ◽  
...  

MedChemComm ◽  
2017 ◽  
Vol 8 (2) ◽  
pp. 452-464 ◽  
Author(s):  
Syed Mobasher Ali Abid ◽  
Sana Aslam ◽  
Sumera Zaib ◽  
Syeda Mahwish Bakht ◽  
Matloob Ahmad ◽  
...  

Binding mode of potent inhibitor (green) & cognate ligand (pink) in the active site of MAO-B.


ChemInform ◽  
2010 ◽  
Vol 27 (19) ◽  
pp. no-no
Author(s):  
P. F. JACKSON ◽  
D. C. COLE ◽  
B. S. SLUSHER ◽  
S. L. STETZ ◽  
L. E. ROSS ◽  
...  

2021 ◽  
Author(s):  
Dongxing Chen ◽  
Ying Meng ◽  
Dan Yu ◽  
Nicholas Noinaj ◽  
Xiaodong Cheng ◽  
...  

Understanding the selectivity of methyltransferase inhibitors is important to dissect the functions of each methyltransferase target. From this perspective, here we report a chemoproteomic study to profile the selectivity of a potent protein N-terminal methyltransferase 1 (NTMT1) bisubstrate inhibitor NAH-C3-GPKK (Ki, app = 7 nM) in endogenous proteomes. First, we describe the rational design, synthesis, and biochemical characterization of a new chemical probe 6, a biotinylated analogue of NAH-C3-GPKK. Next, we systematically analyze protein networks that may selectively interact with the biotinylated probe 6 in concert with the competitor NAH-C3-GPKK. Besides NTMT1, the designated NTMT1 bisubstrate inhibitor NAH-C3-GPKK was found to also potently inhibit a methyltransferase complex HemK2-Trm112 (also known as KMT9-Trm112), highlighting the importance of systematic selectivity profiling. Furthermore, this is the first potent inhibitor for HemK2/KMT9 reported to date. Thus, our studies lay the foundation for future efforts towards the development of selective inhibitors for NTMT1 and HemK2/KMT9.


2017 ◽  
Vol 60 (12) ◽  
pp. 5002-5014 ◽  
Author(s):  
Grazia Piizzi ◽  
David T. Parker ◽  
Yunshan Peng ◽  
Markus Dobler ◽  
Anup Patnaik ◽  
...  

Biochemistry ◽  
2003 ◽  
Vol 42 (20) ◽  
pp. 6043-6056 ◽  
Author(s):  
Yan Zhang ◽  
Joel Desharnais ◽  
Thomas H. Marsilje ◽  
Chenglong Li ◽  
Michael P. Hedrick ◽  
...  

2005 ◽  
Vol 48 (17) ◽  
pp. 5504-5508 ◽  
Author(s):  
Jeremy L. Clark ◽  
Laurent Hollecker ◽  
J. Christian Mason ◽  
Lieven J. Stuyver ◽  
Phillip M. Tharnish ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document